

CLINVET SOUTH AFRICA
Farm: 220 Hectares (+/- 544 Acres)
Facilities: 51 Buildings (26,500 sqm/285,000 sqft)
Staff: 100 Team members
Regulatory Standards: SANS10386, European Directive 2010/63/EU. GLP and (VICH GL9) GCPv approved facility.
Capabilities
The facilities include canine and feline breeding, rearing, colony and study units for our large purpose bred, reuse canine and feline animal colony. Communal housing facilities are available for ruminants and equines, and individual stanchions for cattle. Rodents are housed in a dedicated ABSL2+ unit. The facilities allow for a vast diversity of projects and range from open, to climate-controlled and ABSL2+ research units, and veterinary care facilities, including clinics and a fully equipped surgical theatre. The large arthropod and helminth breeding unit holds a comprehensive parasite bank with strains from around the world and supplies most of the parasites, helminths, and insects used in projects. A state-of-the-art clinical pathology laboratory is situated on site and can support most of the work performed.
Primary Focus
We design and perform safety, efficacy, and metabolism studies on ectoparasiticides, endoparasiticides, and veterinary medicines for candidate screening and product registration or label extension. Our studies are typically submitted to EMA, EPA, VMD, FDA, USDA, ANSES, AEMPS, MAFF, VDD, MAPA, APVMA, DALRRD, SAHPRA, and other regulatory authorities. We also perform field and laboratory pesticide efficacy testing for the chemical and public health industries.

CLINVET MOROCCO
Farm: 22 Hectares (+/- 54 Acres)
Facilities: 22 Buildings (13,700 sqm/150,000 sqft)
Staff: 60 Team members
Regulatory Standards: European Directive 2010/63/EU. (VICH GL9) GCPv.
Capabilities
The facilities include an arthropod and insect (sandflies) breeding unit, canine breeding and rearing facilities, and outdoor and indoor large & companion animal accommodation. The canine research facilities consist of insect-and-arthropod-proof and open and semi-open communal facilities. Ruminants, equines, and poultry can be housed, as applicable, in holding and sorting pens, isolation corrals, insect-proof, and two research facilities up to ABSL2 and 2+. We also have veterinary care facilities with a fully-equipped clinic and surgical theatre.
Primary Focus
The Moroccan site opened in 2015 to expand Clinvet’s footprint in Africa and support research on infectious diseases affecting companion animals in the Mediterranean basin – including heartworm, leishmaniosis, and associated vectors. The ABSL2+ production animal facility and the library of recent African ectoparasite isolates provide the possibility to perform clinical trials on the most significant ticks and tick-borne diseases affecting farmers on the African continent and further afield.

CLINVET NEW YORK
Farm: 56 Hectares (138 Acres)
Facilities: 26 Buildings (7,700 sqm/82,600 sqft)
Staff: 50 Team members
Regulatory Standards: AAALAC Accredited, USDA Licensed, and OECD GLPs as well as (VICH GL9) GCPv.
Capabilities
The site consists of 26 buildings located in two locations. Animal housing spaces include conventional ABSL2 and ABSL2+ barrier facilities for cats and dogs. Our modular and flexible housing system allows various configurations in different rooms and buildings, and support areas include various laboratory spaces, procedure rooms, and a surgery and recovery area.
Primary Focus
Clinvet USA (NY) conducts efficacy, safety, metabolism, and immunogenicity studies in conventional and APD canines and felines. The site has experienced researchers and various animal housing spaces, including barrier facilities suitable for infectious disease challenge trials. Our parasitology-experienced team and access to companion animal ecto and endo parasite strains allow us to support parasitology efficacy studies.

CLINVET SOUTH DAKOTA
Farm: 22 Hectares (56 Acres)
Facilities: 5 Buildings (3,400 sqm/36,700 sqft)
Staff: 20 Team members
Regulatory Standards: USDA 9CFR, AVMA
Capabilities
Clinvet South Dakota (CVSD) performs bovine, swine, and avian clinical studies, including but not limited to reversion to virulence, tissue tropism, duration of immunity, fetal protection, lack of interference, viral and bacterial challenge studies, parasitology natural challenge studies, growth and feed performance, and more.
Primary Focus
Clinvet South Dakota (CVSD) focuses on food-producing species, notably bovine, swine, and avian. The scientific team has over 20 years of experience designing and conducting safety and efficacy studies to support novel biological products’ R&D and existing products’ post-license maintenance. Its scientific expertise and microbiology laboratory enable the site to develop, validate, and execute viral and bacterial disease challenge models. CVSD studies support product registrations with USDA, EMA, and other local authorities.

OcciLife - France
Surface: 2 Hectares (5 Acres)
Facilities: 5 Buildings (3,400 sqm/36,700 sqft)
Staff: 17 Team members
Regulatory Standards: AAALAC Accredited, OECD GLP Accredited
Capabilities
The site comprises two buildings dedicated to study activities and four movable modules. Animal housing space includes conventional canine, feline, rodent, and mini pigs facilities. Our flexible housing systems and multi-expertise allow various configurations in different rooms and support areas, such as laboratories, examination rooms, surgery theatre, and recovery areas.
Primary Focus
Occilife conducts efficacy, safety, and metabolism studies in conventional canines, felines, rodents, and mini pigs. The site’s experienced technical and scientific team has supported animal and human health product development for over 25 years and has validated an array of 3Rs principle-based research models (such as acute pain and wound healing) to accelerate innovation.